Cargando…

Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019

We examined the epidemiological trends, including the distribution of sex, age, and disease etiology, in HCC incident cases, over 24 years. Data of 20,547 HCC patients (1996–2019) were analyzed in this prospective study. We divided the study period into four 6-yearly quarters. HCC etiology was categ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, Masahito, Yatsuhashi, Hiroshi, Bekki, Shigemune, Takami, Yuko, Tanaka, Yasuhito, Yoshimaru, Yoko, Honda, Koichi, Komorizono, Yasuji, Harada, Masaru, Shibata, Michihiko, Sakisaka, Shotaro, Shakado, Satoshi, Nagata, Kenji, Yoshizumi, Tomoharu, Itoh, Shinji, Sohda, Tetsuro, Oeda, Satoshi, Nakao, Kazuhiko, Sasaki, Ryu, Yamashita, Tsutomu, Ido, Akio, Mawatari, Seiichi, Nakamuta, Makoto, Aratake, Yoshifusa, Matsumoto, Shuichi, Maeshiro, Tatsuji, Goto, Takashi, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795252/
https://www.ncbi.nlm.nih.gov/pubmed/35087153
http://dx.doi.org/10.1038/s41598-022-05444-z
_version_ 1784641021302276096
author Nakano, Masahito
Yatsuhashi, Hiroshi
Bekki, Shigemune
Takami, Yuko
Tanaka, Yasuhito
Yoshimaru, Yoko
Honda, Koichi
Komorizono, Yasuji
Harada, Masaru
Shibata, Michihiko
Sakisaka, Shotaro
Shakado, Satoshi
Nagata, Kenji
Yoshizumi, Tomoharu
Itoh, Shinji
Sohda, Tetsuro
Oeda, Satoshi
Nakao, Kazuhiko
Sasaki, Ryu
Yamashita, Tsutomu
Ido, Akio
Mawatari, Seiichi
Nakamuta, Makoto
Aratake, Yoshifusa
Matsumoto, Shuichi
Maeshiro, Tatsuji
Goto, Takashi
Torimura, Takuji
author_facet Nakano, Masahito
Yatsuhashi, Hiroshi
Bekki, Shigemune
Takami, Yuko
Tanaka, Yasuhito
Yoshimaru, Yoko
Honda, Koichi
Komorizono, Yasuji
Harada, Masaru
Shibata, Michihiko
Sakisaka, Shotaro
Shakado, Satoshi
Nagata, Kenji
Yoshizumi, Tomoharu
Itoh, Shinji
Sohda, Tetsuro
Oeda, Satoshi
Nakao, Kazuhiko
Sasaki, Ryu
Yamashita, Tsutomu
Ido, Akio
Mawatari, Seiichi
Nakamuta, Makoto
Aratake, Yoshifusa
Matsumoto, Shuichi
Maeshiro, Tatsuji
Goto, Takashi
Torimura, Takuji
author_sort Nakano, Masahito
collection PubMed
description We examined the epidemiological trends, including the distribution of sex, age, and disease etiology, in HCC incident cases, over 24 years. Data of 20,547 HCC patients (1996–2019) were analyzed in this prospective study. We divided the study period into four 6-yearly quarters. HCC etiology was categorized as hepatitis B virus (HBV) infection, HBV + hepatitis C virus (HCV) infection, HCV infection, and both negative (non-BC). The incident cases of HCC per quarter of the study period were 4311 (21.0%), 5505 (26.8%), 5776 (28.1%), and 4955 (24.1%), sequentially. Overall, 14,020 (68.2%) patients were male. The number of HCC cases in patients < 60 years, 60–69 years, 70–79 years, and ≥ 80 years were 3711 (18.1%), 6652 (32.4%), 7448 (36.2%), and 2736 (13.3%), respectively. The average age of newly-diagnosed patients increased in each quarter. HCC was associated with HBV, HBV + HCV, and HCV infections and non-BC in 2997 (14.6%), 187 (0.9%), and 12,019 (58.5%), and 5344 (26.0%) cases, respectively. The number of HCV-associated cases decreased in each quarter, while that of non-BC-associated cases increased. HCC incident cases tend to increase in the elderly and in non-BC patients; in contrast, HCC incident cases due to HCV tend to decrease.
format Online
Article
Text
id pubmed-8795252
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87952522022-01-28 Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 Nakano, Masahito Yatsuhashi, Hiroshi Bekki, Shigemune Takami, Yuko Tanaka, Yasuhito Yoshimaru, Yoko Honda, Koichi Komorizono, Yasuji Harada, Masaru Shibata, Michihiko Sakisaka, Shotaro Shakado, Satoshi Nagata, Kenji Yoshizumi, Tomoharu Itoh, Shinji Sohda, Tetsuro Oeda, Satoshi Nakao, Kazuhiko Sasaki, Ryu Yamashita, Tsutomu Ido, Akio Mawatari, Seiichi Nakamuta, Makoto Aratake, Yoshifusa Matsumoto, Shuichi Maeshiro, Tatsuji Goto, Takashi Torimura, Takuji Sci Rep Article We examined the epidemiological trends, including the distribution of sex, age, and disease etiology, in HCC incident cases, over 24 years. Data of 20,547 HCC patients (1996–2019) were analyzed in this prospective study. We divided the study period into four 6-yearly quarters. HCC etiology was categorized as hepatitis B virus (HBV) infection, HBV + hepatitis C virus (HCV) infection, HCV infection, and both negative (non-BC). The incident cases of HCC per quarter of the study period were 4311 (21.0%), 5505 (26.8%), 5776 (28.1%), and 4955 (24.1%), sequentially. Overall, 14,020 (68.2%) patients were male. The number of HCC cases in patients < 60 years, 60–69 years, 70–79 years, and ≥ 80 years were 3711 (18.1%), 6652 (32.4%), 7448 (36.2%), and 2736 (13.3%), respectively. The average age of newly-diagnosed patients increased in each quarter. HCC was associated with HBV, HBV + HCV, and HCV infections and non-BC in 2997 (14.6%), 187 (0.9%), and 12,019 (58.5%), and 5344 (26.0%) cases, respectively. The number of HCV-associated cases decreased in each quarter, while that of non-BC-associated cases increased. HCC incident cases tend to increase in the elderly and in non-BC patients; in contrast, HCC incident cases due to HCV tend to decrease. Nature Publishing Group UK 2022-01-27 /pmc/articles/PMC8795252/ /pubmed/35087153 http://dx.doi.org/10.1038/s41598-022-05444-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Nakano, Masahito
Yatsuhashi, Hiroshi
Bekki, Shigemune
Takami, Yuko
Tanaka, Yasuhito
Yoshimaru, Yoko
Honda, Koichi
Komorizono, Yasuji
Harada, Masaru
Shibata, Michihiko
Sakisaka, Shotaro
Shakado, Satoshi
Nagata, Kenji
Yoshizumi, Tomoharu
Itoh, Shinji
Sohda, Tetsuro
Oeda, Satoshi
Nakao, Kazuhiko
Sasaki, Ryu
Yamashita, Tsutomu
Ido, Akio
Mawatari, Seiichi
Nakamuta, Makoto
Aratake, Yoshifusa
Matsumoto, Shuichi
Maeshiro, Tatsuji
Goto, Takashi
Torimura, Takuji
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
title Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
title_full Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
title_fullStr Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
title_full_unstemmed Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
title_short Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
title_sort trends in hepatocellular carcinoma incident cases in japan between 1996 and 2019
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795252/
https://www.ncbi.nlm.nih.gov/pubmed/35087153
http://dx.doi.org/10.1038/s41598-022-05444-z
work_keys_str_mv AT nakanomasahito trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT yatsuhashihiroshi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT bekkishigemune trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT takamiyuko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT tanakayasuhito trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT yoshimaruyoko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT hondakoichi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT komorizonoyasuji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT haradamasaru trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT shibatamichihiko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT sakisakashotaro trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT shakadosatoshi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT nagatakenji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT yoshizumitomoharu trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT itohshinji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT sohdatetsuro trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT oedasatoshi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT nakaokazuhiko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT sasakiryu trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT yamashitatsutomu trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT idoakio trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT mawatariseiichi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT nakamutamakoto trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT aratakeyoshifusa trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT matsumotoshuichi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT maeshirotatsuji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT gototakashi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019
AT torimuratakuji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019